CAMP4 Therapeutics Corporation (CAMP) financial statements and ratios from SEC XBRL: revenue $3.50M (TTM), net margin -2298.5%, revenue growth 436.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.50M |
| Net Margin | -2298.5% |
| Revenue Growth (YoY) | 436.5% |
| EPS Growth (YoY) | -76.0% |
| FCF Growth (YoY) | -35.2% |
| Price / Sales | 54.34 |
| FCF Yield | -29.2% |
| Altman Z-Score | -1.92 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CAMP overview · CAMP earnings · CAMP KPIs · CAMP investor relations · CAMP ownership · CAMP peers · CAMP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.